Sana Biotechnology, Inc. (SANA) NASDAQ
3.24
+0.03(+0.93%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.03B |
| Enterprise Value | 1.04B |
| P/E Ratio | -3.71 |
| PEG Ratio | 0.37 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 7.52 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -4.96 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.65 |
| Return On Equity | -1.62 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -12.75M |
| EBITDA | -178.21M |
| Net Income | -244.17M |
| Diluted EPS | -0.96 |
Balance Sheet
| Total Cash | 101.14M |
| Total Cash/Share | 0.37 |
| Total Debt | 75.33M |
| Total Debt/Equity | 0.63 |
| Current Ratio | 1.29 |
| Book Value Per Share | 0.43 |
Price History
| 52-Week Change | 47.27 |
| 52-Week High | 6.55 |
| 52-Week Low | 2.1 |
| Moving Average 50 Days | 3.24 |
| Moving Average 200 Days | 3.86 |
Statistics
| Average Volume | 3.65M |
| Shares Outstanding | 278.29M |
| % Held by Institutions | 64.8 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
